posting velocity //
Loading…
Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.
Based on 6 events over 48 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
role mix //
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
Active openings by region. Click a row to see jobs in that area.
time on market //
Median
0.0 days
25th pct
0.0 days
75th pct
Soon
Based on 2 closed jobs and 2 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.Still collecting — median tracking age is ~12.6 days (need 14+). 100% of closures were within 3 days, which often reflects feed churn rather than hires.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
—
Fewer than 10 closures in the window — not enough to compute.
hiring signal · from our data
From our job data · always current
2 open roles in Israel
Live openings we track — Israel first, plus worldwide when we have them.
Top roles
news feed
<p>TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ecopipam, a first-in-class investigational therapy for the treatment of pediatric Tourette syndrome.</p>
Jun 18, 2026
<a href="https://news.google.com/rss/articles/CBMioAJBVV95cUxQVklYaXJaSGtDYkpVWGpRNW1lczVFZDJ5ejJ3NVptQU5lN09kX2tEeGpYNDBWUmlEc1JpZ3dlajFVVVlJMldpYUlZZTAzaGNhNnB0YXI3YXloMElUXzlDWkhtUkVGRXdlNWQxTDZ2c2lIVHBudWpVZlAwN2s2dGNDRUQ2S1Y5X1ZaME1Yc1Y2Mko0M3pxNTZtUWJRQ3I0S3VJWE85MFJZZTYzeEUtY1FSOXZqdS13SW1teVhocmVYOXJVdXFxSEJWODZUTUtkWUxXMkNWLUMtU2pnbll1TG1HalAyS3BxMkFmdjRaVFNDM18xR1F2a2VURjMzUF91VzRRd1dRdG5OUWF0dHJLNkFTVjVkbnlhODN1S3dKUFRGd2o?oc=5" target="_blank">Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer</a> <font color="#6f6f6f">PR Newswire</font>
Apr 30, 2026
<p>For more than a decade, NoCamels has written about every aspect of Israel’s high-tech sector, from medical breakthroughs for treatment of deadly diseases to digital developments for both work and leisure and greentech to preserve our struggling planet. Here are five favorites from us and five from you, our loyal readers: Our Picks:  Cancer Cures With […]</p> <p>The post <a href="https://nocamels.com/2024/10/editors-readers-choice-10-favorite-nocamels-articles/">Editors’ & Readers’ Choice: 10 Favorite NoCamels Articles</a> appeared first on <a href="https://nocamels.com">NoCamels</a>.</p>
Oct 31, 2024
<p>An Israeli company that develops cannabis-based therapeutics says its CBD injections have proven effective in providing pain relief for dogs with naturally occurring osteoarthritis. According to InnoCan Pharma, a long-term treatment plan consistently demonstrated the LPT-CBD injection’s efficacy in pain reduction and improved mobility, with the effects lasting for several weeks after each treatment. This, […]</p> <p>The post <a href="https://nocamels.com/2024/10/cannabis-therapy-firm-cbd-jab-reduces-pain-in-arthritic-dogs/">Cannabis Therapy Firm: CBD Jab Reduces Pain In Arthritic Dogs </a> appeared first on <a href="https://nocamels.com">NoCamels</a>.</p>
Oct 15, 2024